The toxicity, protective action against radiation injury and inhibition of DNA synthesis, and rejoining process by cysteamine and cystamine have been studied in cultured mammalian cells with the following results. Cysteamine (a) Toxicity: Although cysteamine in high concentrations is nontoxic, it is toxic in relatively low concentrations (0.5 mM). In low concentrations, it induces single-strand breaks of DNA in the irradiated and nonirradiated cells, depresses DNA synthesis in nonirradiated cells, and depresses the rate of rejoining of radiation-induced single-strand breaks of DNA in irradiated cells. (b) Protection against radiation damage: Cysteamine (over 5 mM) protects DNA molecules from radiation-induced single-strand breaks and double-strand cuts. The degree of protection by cysteamine increases with increasing cysteamine concentrations. (c) Inhibition of DNA synthesis and rejoining process: Cysteamine in high concentrations (over 5 mM) inhibits normal DNA synthesis of the nonirradiated cells and slows the rejoining of radiation-induced single-strand breaks in irradiated cells. Cystamine. Cystamine shows no toxic effect and affords little protection for DNA molecules from radiation-induced single-strand breaks. However, cystamine inhibits DNA synthesis of nonirradiated cells and the rejoining process of irradiated cells.
Skip Nav Destination
Close
Article navigation
1 October 1970
Research Article|
October 01 1970
Cysteamine, Cystamine, and Single-Strand Breaks of DNA in Cultured Mammalian Cells
Radiat Res (1970) 44 (1): 116–132.
Citation
S. Sawada, S. Okada; Cysteamine, Cystamine, and Single-Strand Breaks of DNA in Cultured Mammalian Cells. Radiat Res 1 October 1970; 44 (1): 116–132. doi: https://doi.org/10.2307/3573177
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group
Hualin Zhang, Xiaodong Wu, Xin Zhang, Sha X. Chang, Ali Megooni, Eric D. Donnelly, Mansoor M. Ahmed, Robert J. Griffin, James S. Welsh, Charles B. Simone, II, Nina A. Mayr
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner